Turner SD - Search Results

1

Twenty years of modelling NPM-ALK-induced lymphomagenesis.

Giuriato S, Turner SD. Giuriato S, et al. Among authors: turner sd. Front Biosci (Schol Ed). 2015 Jun 1;7(2):236-47. doi: 10.2741/S437. Front Biosci (Schol Ed). 2015. PMID: 25961699 Free article. Review.

2

CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy.

Turner SD, Merz H, Yeung D, Alexander DR. Turner SD, et al. Anticancer Res. 2006 Sep-Oct;26(5A):3275-9. Anticancer Res. 2006. PMID: 17094440 Free article.

3

The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms.

Turner SD, Yeung D, Hadfield K, Cook SJ, Alexander DR. Turner SD, et al. Cell Signal. 2007 Apr;19(4):740-7. doi: 10.1016/j.cellsig.2006.09.007. Epub 2006 Oct 4. Cell Signal. 2007. PMID: 17110082

4

NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner.

Cui YX, Kerby A, McDuff FK, Ye H, Turner SD. Cui YX, et al. Among authors: turner sd. Blood. 2009 May 21;113(21):5217-27. doi: 10.1182/blood-2008-06-160168. Epub 2009 Mar 13. Blood. 2009. PMID: 19286999 Free article.

5

Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study.

Youssif C, Goldenbogen J, Hamoudi R, Carreras J, Viskaduraki M, Cui YX, Bacon CM, Burke GA, Turner SD. Youssif C, et al. Among authors: turner sd. Genes Chromosomes Cancer. 2009 Nov;48(11):1018-26. doi: 10.1002/gcc.20701. Genes Chromosomes Cancer. 2009. PMID: 19691112

6

Aberrant anaplastic lymphoma kinase activity induces a p53 and Rb-dependent senescence-like arrest in the absence of detectable p53 stabilization.

McDuff FK, Turner SD. McDuff FK, et al. Among authors: turner sd. PLoS One. 2011 Mar 14;6(3):e17854. doi: 10.1371/journal.pone.0017854. PLoS One. 2011. PMID: 21423761 Free PMC article.

7

Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis.

Mduff FK, Hook CE, Tooze RM, Huntly BJ, Pandolfi PP, Turner SD. Mduff FK, et al. Among authors: turner sd. Lab Invest. 2011 Sep;91(9):1298-303. doi: 10.1038/labinvest.2011.96. Epub 2011 Jun 27. Lab Invest. 2011. PMID: 21709672 Free PMC article.

8

Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants.

McDuff FK, Lim SV, Dalbay M, Turner SD. McDuff FK, et al. Among authors: turner sd. Mol Carcinog. 2013 Jan;52(1):79-83. doi: 10.1002/mc.21836. Epub 2011 Nov 15. Mol Carcinog. 2013. PMID: 22086496

9

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.

Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L. Laimer D, et al. Among authors: turner sd. Nat Med. 2012 Nov;18(11):1699-704. doi: 10.1038/nm.2966. Epub 2012 Oct 14. Nat Med. 2012. PMID: 23064464 Free article.

10

Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence.

Ye X, Shokrollahi K, Rozen WM, Conyers R, Wright P, Kenner L, Turner SD, Whitaker IS. Ye X, et al. Among authors: turner sd. Mutat Res Rev Mutat Res. 2014 Oct-Dec;762:123-32. doi: 10.1016/j.mrrev.2014.08.002. Epub 2014 Aug 23. Mutat Res Rev Mutat Res. 2014. PMID: 25475421 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters